Introduction
(Kiran Kaur)
In the dynamic landscape of the pharmaceutical industry, the effective integration of information systems into product development processes is pivotal for success. This report aims to explore the business processes and competitive strategies of Bristol Myers Squibb (BMS), a global pharmaceutical giant dedicated to addressing severe illnesses such as cancer, diabetes, HIV/AIDS, cardiovascular disease, and psychiatric disorders. The primary objective of this report is to comprehensively research and understand Bristol Myers Squibb’s information systems, and most critically, how it can optimize its systems to support the company’s business processes. This report centers around the thesis that a detailed examination and improvement of the management information systems at BMS will not only refine internal operations but also contribute significantly to the company's mission of delivering life-changing medicines.
Under the guidance of Catherine Francisco, an experienced IT Business Partner at BMS with a managerial background at several companies including Pfizer and Merck, this study benefits from insightful leadership. With over three years of experience in her current role, Ms. Francisco provides a valuable managerial perspective for understanding and refining information systems and business processes. Bristol Myers Squibb, boasting a net income of $6.32 billion as of 2022, operates across approximately 25 locations worldwide. These locations serve various functions, from manufacturing and research & development to commercial regulatory, data management, finance, HR, IT, and product development. With a portfolio dedicated to addressing severe illnesses, BMS caters to a broad target audience – patients and individuals in need of treatments for serious diseases or conditions, including cancer, diabetes, HIV/AIDS, cardiovascular disease, and psychiatric disorders. The scale of operations is reflected in the company's workforce, which stands at 34,300 employees as of 2022. This expansive team collaborates to drive innovation and bring life-saving medicines to those in need. In the following sections, this report will dive into the specifics of Bristol Myers Squibb's product development process, identifying strengths and presenting opportunities for improvement.
